Diabetes drug tested to boost chemo against aggressive cancers
NCT ID NCT02122185
Summary
This study tested whether adding the common diabetes medication metformin to standard chemotherapy could better control advanced cancers of the ovary, fallopian tube, or abdominal lining. It involved 111 non-diabetic patients who were randomly assigned to receive either metformin or a placebo pill alongside their chemotherapy, followed by up to two years of the assigned pill. The main goal was to see if the metformin group experienced a longer period without their cancer getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN ENDOMETRIOID ADENOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
City of Hope
Duarte, California, 91010, United States
-
Decatur Memorial Hospital
Decatur, Illinois, 62526, United States
-
Ingalls Memorial Hospital
Harvey, Illinois, 60426, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Mitchell Cancer Institute - University of South Alabama
Mobile, Alabama, 36604, United States
-
NCH Medical Group- Northwest Community Hospital
Arlington Heights, Illinois, 60005, United States
-
NorthShore University HealthSystem
Evanston, Illinois, 60201, United States
-
Rush University Medical Center
Chicago, Illinois, 60612, United States
-
University of Alabama
Birmingham, Alabama, 35233, United States
-
University of Chicago
Chicago, Illinois, 60637, United States
Conditions
Explore the condition pages connected to this study.